r phycocrythrin rpe conjugated mouse anti canine cd21 antibody (Bio-Rad)
Bio-Rad is a verified supplier 
Bio-Rad manufactures this product 
93
Structured Review
Bio-Rad
r phycocrythrin rpe conjugated mouse anti canine cd21 antibody
R Phycocrythrin Rpe Conjugated Mouse Anti Canine Cd21 Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 91 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd21/Mouse+anti+Canine+CD21/us09790280-470-34-40
Average 93 stars, based on 91 article reviews
R Phycocrythrin Rpe Conjugated Mouse Anti Canine Cd21 Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 91 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd21/Mouse+anti+Canine+CD21/us09790280-470-34-40
Average 93 stars, based on 91 article reviews
r phycocrythrin rpe conjugated mouse anti canine cd21 antibody - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
FACS:Article Title: Monoclonal antibodies and methods of use Article Snippet: .. From these blood samples, clinical pathology parameters were monitored and the percent of CD21-positive lymphocytes (B cells) in each dog were analyzed in triplicate by FACS on PBMC isolated from whole blood using a Article Title: Monoclonal antibodies and methods of use Article Snippet: .. From these blood samples, clinical pathology parameters are monitored and the percent of CD21-positive lymphocytes (B cells) in each dog are analyzed in triplicate by FACS on PBMC isolated from whole blood using a Isolation:Article Title: Monoclonal antibodies and methods of use Article Snippet: .. From these blood samples, clinical pathology parameters were monitored and the percent of CD21-positive lymphocytes (B cells) in each dog were analyzed in triplicate by FACS on PBMC isolated from whole blood using a Article Title: Monoclonal antibodies and methods of use Article Snippet: .. From these blood samples, clinical pathology parameters are monitored and the percent of CD21-positive lymphocytes (B cells) in each dog are analyzed in triplicate by FACS on PBMC isolated from whole blood using a Suspension:Article Title: Development of canine parvovirus-neutralizing monoclonal antibodies from natural host and their germline gene usage Article Snippet: .. The cell suspension was incubated with fluorescein isothiocyanate (FITC)-conjugated anti-dog IgM (Bio-Rad Laboratories, Hercules, CA, USA), phycoerythrin (PE)-conjugated Article Title: Development of canine parvovirus-neutralizing monoclonal antibodies from natural host and their germline gene usage. Article Snippet: .. The cell suspension was incubated with fluorescein isothiocyanate (FITC)-conjugated anti-dog IgM (Bio-Rad Laboratories, Hercules, CA, USA), phycoerythrin (PE)-conjugated Incubation:Article Title: Development of canine parvovirus-neutralizing monoclonal antibodies from natural host and their germline gene usage Article Snippet: .. The cell suspension was incubated with fluorescein isothiocyanate (FITC)-conjugated anti-dog IgM (Bio-Rad Laboratories, Hercules, CA, USA), phycoerythrin (PE)-conjugated Article Title: Development of canine parvovirus-neutralizing monoclonal antibodies from natural host and their germline gene usage. Article Snippet: .. The cell suspension was incubated with fluorescein isothiocyanate (FITC)-conjugated anti-dog IgM (Bio-Rad Laboratories, Hercules, CA, USA), phycoerythrin (PE)-conjugated Immunodepletion:Article Title: Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Article Snippet: Article Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Graphical abstract Highlights • Cyclic STAT3 decoy (CS3D) inhibits murine HNSCC tumors via CD8+ cells • CS3D is well tolerated in a clinical trial of pet cats with oral cancer • CS3D induces a 35% disease control rate in pet cats with oral cancer • Analysis of the clinical trial specimens identifies potential predictive biomarkers Authors Jennifer R. Grandis, Katherine A. Skorupski, Ning Cheng, ..., Adam B. Olshen, Ellen E. Sparger, Daniel E. Johnson Correspondence jennifer.grandis@ucsf.edu (J.R.G.), daniel.johnson@ucsf.edu (D.E.J.). In brief Grandis et al. evaluate the activity of a cyclic oligonucleotide inhibitor of STAT3, CS3D, in immunocompetent models of mouse head and neck cancer and in a clinical trial of pet cats with oral cancer.. CS3D has low toxicity and modulation of immune parameters is associated with anti-tumor activity. Control:Article Title: Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Article Snippet: Article Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Graphical abstract Highlights • Cyclic STAT3 decoy (CS3D) inhibits murine HNSCC tumors via CD8+ cells • CS3D is well tolerated in a clinical trial of pet cats with oral cancer • CS3D induces a 35% disease control rate in pet cats with oral cancer • Analysis of the clinical trial specimens identifies potential predictive biomarkers Authors Jennifer R. Grandis, Katherine A. Skorupski, Ning Cheng, ..., Adam B. Olshen, Ellen E. Sparger, Daniel E. Johnson Correspondence jennifer.grandis@ucsf.edu (J.R.G.), daniel.johnson@ucsf.edu (D.E.J.). In brief Grandis et al. evaluate the activity of a cyclic oligonucleotide inhibitor of STAT3, CS3D, in immunocompetent models of mouse head and neck cancer and in a clinical trial of pet cats with oral cancer.. CS3D has low toxicity and modulation of immune parameters is associated with anti-tumor activity. Recombinant:Article Title: Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Article Snippet: Article Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Graphical abstract Highlights • Cyclic STAT3 decoy (CS3D) inhibits murine HNSCC tumors via CD8+ cells • CS3D is well tolerated in a clinical trial of pet cats with oral cancer • CS3D induces a 35% disease control rate in pet cats with oral cancer • Analysis of the clinical trial specimens identifies potential predictive biomarkers Authors Jennifer R. Grandis, Katherine A. Skorupski, Ning Cheng, ..., Adam B. Olshen, Ellen E. Sparger, Daniel E. Johnson Correspondence jennifer.grandis@ucsf.edu (J.R.G.), daniel.johnson@ucsf.edu (D.E.J.). In brief Grandis et al. evaluate the activity of a cyclic oligonucleotide inhibitor of STAT3, CS3D, in immunocompetent models of mouse head and neck cancer and in a clinical trial of pet cats with oral cancer.. CS3D has low toxicity and modulation of immune parameters is associated with anti-tumor activity. Modification:Article Title: Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Article Snippet: Article Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Graphical abstract Highlights • Cyclic STAT3 decoy (CS3D) inhibits murine HNSCC tumors via CD8+ cells • CS3D is well tolerated in a clinical trial of pet cats with oral cancer • CS3D induces a 35% disease control rate in pet cats with oral cancer • Analysis of the clinical trial specimens identifies potential predictive biomarkers Authors Jennifer R. Grandis, Katherine A. Skorupski, Ning Cheng, ..., Adam B. Olshen, Ellen E. Sparger, Daniel E. Johnson Correspondence jennifer.grandis@ucsf.edu (J.R.G.), daniel.johnson@ucsf.edu (D.E.J.). In brief Grandis et al. evaluate the activity of a cyclic oligonucleotide inhibitor of STAT3, CS3D, in immunocompetent models of mouse head and neck cancer and in a clinical trial of pet cats with oral cancer.. CS3D has low toxicity and modulation of immune parameters is associated with anti-tumor activity. Staining:Article Title: Rabies vaccination induces a CD4 + T EM and CD4 + CD8 + T EMRA T H 1 phenotype in dogs Article Snippet: After five days of stimulation, cells were harvested and stained with canine Fc block (14-9162-42, ThermoFisher Scientific) for 10 minutes prior to the addition of CD45RA antibody (CA4.1D3, unconjugated, BioRad) for 15 minutes. .. Cells were then washed with sorter buffer, centrifuged and stained at 4°C for 20 minutes with an anti-mouse IgG1 (M1-14D12, Super Bright 780, Invitrogen) as a secondary antibody to detect CD45RA + cells, along with other antibodies directed against CD62L (FMC46, StarBright UltraViolet 605, BioRad), CD4 (YKIX302.9, PE-Cy7, BioRad), CD8 (YCATE55.9, Pacific Blue, BioRad), CD11b (M1/70, FITC, BioLegend), Article Title: Increased Abundance of Cytotoxic T Cells in Synovial Fluid of a Dog With Erosive Immune‐Mediated Polyarthritis Article Snippet: Prepared cell samples were incubated for 10 min with an Fc receptor–binding inhibitor polyclonal antibody (14‐9162‐42; eBioscience, San Diego, California, United States) to prevent nonspecific staining. .. Peripheral blood and synovial fluid were stained for 20 min on ice with fluorescent dye–conjugated monoclonal antibodies specific for the following markers: CD45 (clone YKIX716.13, 48‐5450‐42; eBioscience), CD11b (clone M1/70, 101216; BioLegend, San Diego, California, United States), CD14 (clone TÜK4, MCA1568A647; Bio‐Rad Laboratories, Hercules, California, United States), Article Title: Anti-IgE antibody specifically binding to membrane-bound IgE antibody of IgE antibody-producing B cells and method for diagnosing and treating allergic symptoms using the same Article Snippet: .. The peripheral blood mononuclear cells of a dog clinically suspected of having an allergy symptom were cultured in RPMI1640 medium containing 10% fetal bovine serum and 1 μg/ml concanavalin A (ConA), at 37° C. for 3 days, and stained with an Bioprocessing:Article Title: Increased Abundance of Cytotoxic T Cells in Synovial Fluid of a Dog With Erosive Immune‐Mediated Polyarthritis Article Snippet: Prepared cell samples were incubated for 10 min with an Fc receptor–binding inhibitor polyclonal antibody (14‐9162‐42; eBioscience, San Diego, California, United States) to prevent nonspecific staining. .. Peripheral blood and synovial fluid were stained for 20 min on ice with fluorescent dye–conjugated monoclonal antibodies specific for the following markers: CD45 (clone YKIX716.13, 48‐5450‐42; eBioscience), CD11b (clone M1/70, 101216; BioLegend, San Diego, California, United States), CD14 (clone TÜK4, MCA1568A647; Bio‐Rad Laboratories, Hercules, California, United States), Cell Culture:Article Title: Anti-IgE antibody specifically binding to membrane-bound IgE antibody of IgE antibody-producing B cells and method for diagnosing and treating allergic symptoms using the same Article Snippet: .. The peripheral blood mononuclear cells of a dog clinically suspected of having an allergy symptom were cultured in RPMI1640 medium containing 10% fetal bovine serum and 1 μg/ml concanavalin A (ConA), at 37° C. for 3 days, and stained with an Marker:Article Title: Anti-IgE antibody specifically binding to membrane-bound IgE antibody of IgE antibody-producing B cells and method for diagnosing and treating allergic symptoms using the same Article Snippet: .. The peripheral blood mononuclear cells of a dog clinically suspected of having an allergy symptom were cultured in RPMI1640 medium containing 10% fetal bovine serum and 1 μg/ml concanavalin A (ConA), at 37° C. for 3 days, and stained with an |
